Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Cardiopulmonary Bypass Flow on Renal Function and Oxygenation
NCT02549066Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jan 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of milrinone in heart failure (HF) (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: Renal oxygenation at 10 minutes. Started Jan 2016; status: completed.
02
Drugs
milrinone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02549066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549066.